FDA DEVICE FACTS
Denali™ Vena Cava Filter System – Femoral and Jugular/Subclavian Delivery Kit
Bd
FDA-sourced product information for medical-device development research. Use the official FDA sources at the end of this page when the original public document wording is needed.医療機器開発の調査用に、FDA の公開情報から取った製品情報を示しています。公開文書の原文が必要なときは、このページの最後にある FDA の公式な出典をご覧ください。
Indications for use
The Denali™ Filter is indicated for use in the prevention of recurrent pulmonary embolism via placement in the vena cava in the following situations: -Pulmonary thromboembolism when anticoagulants are contraindicated -Failure of anticoagulant therapy for thromboembolic disease -Emergency treatment following massive pulmonary embolism where anticipated benefits of conventional therapy are reduced -Chronic, recurrent pulmonary embolism where anticoagulant therapy has failed or is contraindicated. The Denali™ Filter may be removed according to the instructions supplied under the Section labeled: Optional Procedure for Filter Removal.
Device description, AI/software, PCCP, evaluation and limitations are available with an account: seven days of full access after free registration, then with the paid plan.機器の説明、AI・ソフトウェア、PCCP、評価、制限事項は、アカウントでご覧いただけます。無料登録から 7 日間はすべて利用でき、その後は有料プランでご利用いただけます。
OFFICIAL FDA SOURCES
FDA Record and Public Document Status
Record and document link states are stored separately.FDA Record と公開文書のリンクの状態は、別々に記録しています。